جست‌وجوی استاد و پژوهشگر

Jan Frankمشاهده پروفایل

استاد

• Nutritional Sciences
• Food Biochemistry
• Micronutrient Bioavailability
• +۵ مورد دیگر

Professor Jan Frank, Ph.D., leads the Department of Food Biofunctionality at the Institute of Nutritional Sciences , University of Hohenheim. He serves as Dean of the Faculty of Natural Sciences and chairs the Research Center for Health Sciences steering committee. His research focuses on micronutrient bioavailability , vitamin E metabolism , and phytochemical absorption mechanisms using in vitro models and human trials. Key research trends across 137+ publications include: Vitamin E congeners metabolism and pharmacokinetics Curcuminoids and flavonoids bioavailability enhancement Micronutrient interactions in gastrointestinal digestion Phytochemical effects on lipid metabolism and oxidative stress Carotenoids and tocochromanols in food matrices Dietary interventions for metabolic syndrome and aging Awards and editorial roles: Editor-in-Chief of NFS Journal (since 2015) Associate Editor for Nutrition and Plant Foods for Human Nutrition Founding President of the Society of Nutrition and Food Science His laboratory employs in vitro digestion/Caco-2 models , cell culture , and advanced chromatography for studying bioactive compounds. Current grants involve DFG International Research Training Group AMAIZE-P (phosphate-maize interactions) and Carb-Q-4-Health (carbohydrate quality research). Former Ph.D. advisees include Damaris Beitze (DRC maternal nutrition), Semaw Ferede Abera (Ethiopian NCD risks), and Laila Eleraky (Tanzanian farmer nutrition).

• Inflammatory bowel disease
• Eosinophilic esophagitis
• Fibroblast biology
• +۴ مورد دیگر

Dr Mario Manresa is an Assistant Professor (Ad Astra Fellow) in the School of Biomolecular and Biomedical Science at University College Dublin , working from the Conway Institute. He also served as Principal Investigator in the UCD School of Medicine (2022) and held post-doctoral positions at UC San Diego and Harvard Medical School. His research programme dissects how intestinal fibroblasts transition from homeostatic to inflammatory phenotypes and how these cells dialog with innate immune cells in chronic inflammatory disorders such as inflammatory bowel disease (IBD) and eosinophilic esophagitis (EoE). Education & Training PhD – University College Dublin Post-doctoral Fellowship – University of California San Diego, Pediatrics (2018–2021) Post-doctoral Fellowship – Harvard Medical School, Brigham and Women’s Hospital, Pathology (2017–2018) Post-doctoral Fellowship – University College Dublin, Medicine (2016–2017) Research Interests Dr Manresa’s laboratory employs primary human cell culture, co-culture systems, flow cytometry and transcriptomics to understand: molecular drivers (TNF-superfamily cytokines such as TWEAK and LIGHT) that switch fibroblasts toward pathogenic phenotypes; micro-environmental modulators (hypoxia, extracellular matrix composition) shaping fibroblast behaviour; therapeutic restoration of WNT pathway homeostasis to resolve inflammation; interactions between inflammatory fibroblasts and monocytes/macrophages that perpetuate mucosal inflammation. Grant Support & Collaborations UCD Conway Institute Director’s Strategic Award – Ad Astra & Emerging Investigators (2022–2024) Enterprise Ireland / UCD Project Grant – pancreatic cancer-on-chip model of immune cell infiltration (2023–2025) Teaching & Mentoring He coordinates two undergraduate modules—“Cell Signalling” and “Molecular Basis of Disease”—and currently supervises PhD theses, having mentored post-doctoral researcher Carlos Matellan Martin. Professional Service Dr Manresa serves as a peer reviewer for Digestive Diseases Week and is multilingual (English, Spanish, Italian), facilitating international collaboration.

Hassan Fazilatyمشاهده پروفایل

پژوهشگر

• Cancer Biology
• Developmental Genetics
• Tissue Regeneration
• +۳ مورد دیگر

Academic Profile Dr. Hassan Fazilaty is a Research Associate at the University of Zurich's Institute of Molecular Life Sciences, where he investigates embryonic gene reactivation in cancer and regeneration. Previously, he held postdoctoral positions at the University of Zurich and Spain's Instituto de Neurociencias CSIC-UMH. He earned his PhD from Universidad Autonoma de Madrid and an MSc in Human Genetics from Tehran University of Medical Sciences. Research Focus His research integrates developmental biology and oncology, emphasizing: Oncoembryonic Programs : How embryonic genes drive cancer progression. Epithelial-Mesenchymal Transition (EMT) : Mechanisms enabling metastasis. Tissue Regeneration : Embryonic pathways in wound healing and disease. Scientific Recognition Key awards include: Ernst Hadorn Transitional Fellowship (2026–2028) 3RCC Grants for alternatives to animal testing (2021–2025) Santiago Grisolia Fellowship (2014–2017) Lab & Resources He works in Prof. Konrad Basler's lab, which focuses on Wnt signaling and developmental pathways in disease. His projects leverage single-cell genomics and in vivo models, supported by Swiss and EU funding.

Maggie Dallmanمشاهده پروفایل

استاد

• Immunology
• Inflammation
• Autoimmunity
• +۵ مورد دیگر

Professor Maggie Dallman, OBE, is a leading immunologist and Associate Provost (Societal Engagement) at Imperial College London. Her research spans immunoregulation, inflammation, and zebrafish disease models, with key contributions to understanding autoimmune disorders, cancer metastasis, and mucosal immunity. She leads the Dallman Lab, which integrates immunology with advanced imaging technologies. Current roles: Associate Provost (Societal Engagement), Imperial College London Academic affiliations: Faculty of Natural Sciences, Cell and Developmental Biology, Stem Cell Regenerative Medicine Network Her research explores immune responses to pathogens, inflammatory disease mechanisms (e.g., diabetes, rheumatoid arthritis), and therapeutic strategies using zebrafish models. Work includes studying cytokine functions, tumor-induced angiogenesis, and photoswitchable CRISPR tools. Recent publications focus on nanoparticle-based cancer targeting , antiviral nanomimics , zebrafish immunology , and optical tomography innovations . Awards include the Order of the British Empire (OBE) for services to science and education. Scientific awards: Order of the British Empire (OBE) Lab members: PhD students Dory Pólos, Hannah Needham, Madina Wane, Ralf Wenz

Praveen Sethupathyمشاهده پروفایل

استاد

• Physiological Genomics
• Molecular Biology
• Gene Regulation
• +۸ مورد دیگر

Praveen Sethupathy is a Professor of Physiological Genomics at Cornell University's College of Veterinary Medicine. He directs the Sethupathy Lab and the Center for Vertebrate Genomics, focusing on molecular and genome-scale approaches to liver/gut biology and diseases like fibrolamellar carcinoma, diabetes, and Crohn's disease. His team integrates gene regulation , non-coding RNAs , and single-cell genomics with transgenic models. Education: PhD in Genomics (University of Pennsylvania), BA (Cornell University) Research Themes: microRNA mechanisms in epithelial development, systems genetics of disease, cancer biomarker discovery, and translational therapeutics Awards: American Diabetes Association Pathway To Stop Diabetes Research Accelerator (2017) Faculty Merit Award for Teaching Genome Technology Top 25 Investigators (2011) Recent Publications: Focus on microRNA in aging , Crohn's disease transposon signatures , and metabolic rewiring in liver cancer . Funding: NIH, Fibrolamellar Cancer Foundation, American Diabetes Association, Alnylam Pharmaceuticals

• Immunology
• Nutritional Immunology
• Agricultural Immunology
• +۵ مورد دیگر

Willem van Eden is a Full Professor in Immunology and Head of the Division of Immunology within the Department of Veterinary Medicine at Utrecht University, Netherlands. His academic journey began with an MD from the University of Groningen (1978) followed by a PhD from Leiden University (1983) under Professor J.J. van Rood. After completing postdoctoral training at the Weizmann Institute of Science in Israel (1983-1985), he joined Utrecht University where he has served as Associate Professor since 1985 and Full Professor since 1994. Dr. van Eden's research spans multiple immunological domains with particular emphasis on agricultural immunology - a field he helped pioneer through organizing the 2016 Leiden University Lorentz Center workshop 'Innate Immunity of Crops, Livestock and Fish: The Dawn of Agricultural Immunology.' His work bridges veterinary medicine, nutrition, and immunology, focusing on reducing antibiotic use in agriculture through enhanced innate immunity in plants and animals. His research encompasses dendritic cell biology, mucosal immunity, probiotic applications, and the role of heat shock proteins in autoimmune regulation. His publication record demonstrates consistent focus on immune mechanisms applicable to agricultural settings, with recent work examining probiotic interactions with intestinal epithelium, stress-immunity connections, and novel approaches to stimulate immune functions in both livestock and poultry. These studies collectively aim to establish drug-independent food safety systems by strengthening innate immune activity in agricultural production. Dr. van Eden serves as Specialty Chief Editor for Nutritional Immunology at Frontiers in Immunology and as Review Editor for Antigen Presenting Cell Biology. He co-edited the significant Research Topic 'New Horizons in Food Science via Agricultural Immunity' which compiled 11 articles exploring innovative approaches to reduce antibiotics and pesticides in agriculture through enhanced immune function. His professional activities include extensive editorial contributions, with 231 publications and 65 editorial contributions documented. He maintains active research collaborations internationally, particularly with Japanese institutions through the Core-to-Core Program of the Japan Society for the Promotion of Science focused on establishing an international agricultural immunology research core.

Richard DiPaoloمشاهده پروفایل

استاد

• Immunology
• Autoimmune Diseases
• Cancer Research
• +۶ مورد دیگر

Richard DiPaolo is a Professor and Chair of Molecular Microbiology and Immunology at Saint Louis University School of Medicine. He holds a Ph.D. from Washington University School of Medicine and completed his postdoctoral fellowship at NIAID, NIH. Research focuses on immune cell roles in autoimmunity and cancer, particularly CD4+ T regulatory cells (Tregs) and autoreactive T cells. Key diseases studied: Type 1 diabetes, autoimmune gastritis, gastric cancer. Techniques include preclinical mouse models, 3D organoids, T cell receptor sequencing, RNA sequencing, and bioinformatics. His recent work explores metaplasia mechanisms, inflammatory cytokine regulation, and tumor-immune interactions. Collaborations with JC Mills' lab highlight tissue repair dynamics via paligenosis and stem cell pathways. Contact: Doisy Research Center, Saint Louis University | Office: 314-977-8860 | Email: richard.dipaolo@health.slu.edu

Michael N. Hallمشاهده پروفایل

استاد

• Cell Growth
• Metabolism
• TOR Signaling Pathways
• +۶ مورد دیگر

Professor Michael N. Hall is a distinguished faculty member at the Biozentrum of the University of Basel, where he serves as a Professor in the Division of Biochemistry. He also holds a position as Principal Investigator at the Institute of Human Biology, F. Hoffmann-La Roche Ltd in Basel, Switzerland. His career spans over three decades at the University of Basel, where he has held leadership roles including Vice-Director of the Biozentrum and Chairman of the Division of Biochemistry. Dr. Hall's research focuses on TOR (Target of Rapamycin) signaling pathways and their critical role in controlling cell growth, metabolism, and aging. His laboratory investigates these pathways using biochemical, genetic, and cell biological approaches in yeast (Saccharomyces cerevisiae), mammalian cells, mice, and human tumors. His work has revealed fundamental insights into how mTOR (mammalian TOR) regulates metabolic processes and how its dysregulation contributes to diseases including cancer, diabetes, and cardiovascular disorders. Analysis of Professor Hall's recent publications reveals a consistent research trajectory focused on mTOR signaling in health and disease. His work spans basic molecular mechanisms of mTOR complex regulation, translational applications in cancer metabolism, and clinical implications for therapeutic development. A notable trend is the expansion of his research from fundamental yeast genetics to human disease models, particularly in cancer metabolism and liver disease. 2024 Balzan Prize for Biological Mechanisms of Aging 2024 Helis Foundation Lifetime Achievement Award 2023 Grand Medal, French Academy of Sciences 2017 Albert Lasker Basic Medical Research Award 2015 Canada Gairdner International Award for Biomedical Research 2014 Breakthrough Prize in Life Sciences 2014 National Academy of Sciences USA membership 2009 Louis-Jeantet Prize for Medicine Professor Hall has secured significant research funding, including an ERC Synergy Grant (2014-2020) as Corresponding Principal Investigator. His laboratory has trained numerous scientists who have gone on to establish independent research careers. Beyond his own research, Hall serves on multiple scientific advisory boards and selection committees for major international prizes, demonstrating his leadership in the global research community. His research group at the Biozentrum maintains active collaborations with clinicians for translational research projects, particularly in cancer. The laboratory employs a multidisciplinary approach combining molecular biology, biochemistry, and systems biology to understand TOR signaling pathways across different model systems. Hall's work bridges fundamental discovery with potential therapeutic applications, particularly in the development of new approaches for treating diseases involving dysregulated cell growth.

Fengyi Wanمشاهده پروفایل

استاد

• Signal Transduction
• Pathogen-Host-Microbiota Interactions
• RNA-Binding Proteins
• +۳ مورد دیگر

Fengyi Wan , PhD, is a Professor in the Department of Biochemistry and Molecular Biology at the Johns Hopkins University School of Medicine . He also holds a joint appointment in the Molecular Microbiology and Immunology division. His research focuses on understanding the molecular mechanisms of host-pathogen-microbiota interactions in colon health and diseases, particularly mechanisms of signal transduction , RNA-binding proteins , colitis , and colon tumorigenesis . Education: PhD, Chinese Academy of Sciences (2003) BS, Wuhan University (1999) Research Interests : Wan's laboratory investigates how bacterial virulence factors manipulate host immune signaling (NF-κB, TAK1/IKK complex), epithelial barrier functions, and DNA damage responses. Current projects explore complement in breast milk modulating infant microbiota, genotoxins accelerating colon cancer, and adipokine signaling in inflammatory diseases. Recent publications highlight his expertise in NF-κB regulation through bacterial effectors (NleC, NleH), ribosomal protein S3 interactions, and RNA-binding protein Sam68's role in DNA repair and cancer. His work spans mechanistic studies in mouse models of colitis, tumorigenesis, and radiation injury. Scientific Recognition: Howard Temin Pathway to Independence Award (2008) American Cancer Society Research Scholar (2013) Johns Hopkins Catalyst Award (2017) Department of Defense Idea Development Award (2019) Wan's team actively recruits postdoctoral researchers and collaborates with institutions on microbiota-inflammation-cancer axis studies. The lab is located at 615 N. Wolfe Street, Room W8515, Baltimore, MD 21205.

Catherine E. Leimkuhler Grimesمشاهده پروفایل

استاد

• Chemical Biology
• Carbohydrate Chemistry
• Innate Immunity
• +۵ مورد دیگر

Catherine E. Leimkuhler Grimes is a Professor in the Department of Chemistry and Biochemistry at the University of Delaware's College of Arts & Sciences, where she leads a research program at the chemistry-biology interface. Her laboratory develops innovative chemical tools to investigate bacterial cell wall biosynthesis and host immune recognition mechanisms. Her educational background includes a B.S. in Chemistry from Villanova University (2001), M.S. in Chemistry from Princeton University (2003), and Ph.D. in Chemistry and Chemical Biology from Harvard University (2007), followed by a Cancer Research Institute Postdoctoral Fellowship at Harvard/Massachusetts General Hospital (2007-2011). Dr. Leimkuhler Grimes' research focuses on chemical biology approaches to understand innate immune responses to bacterial pathogens, particularly through the development of synthetic carbohydrate probes that mimic peptidoglycan intermediates. Her work integrates organic synthesis, molecular biology, and biochemical techniques to study how bacterial cell wall components trigger immune responses relevant to inflammatory bowel disease and other immune disorders. The lab emphasizes interdisciplinary training and collaborative science. Analysis of her recent publications (2024-2025) reveals expanding research directions into fungal pathogenesis (particularly Candida species), advanced bioorthogonal labeling techniques for live-cell imaging, and novel approaches to model host-pathogen interactions in 3D microenvironments. Her work consistently bridges fundamental chemical synthesis with immunological applications. Her scientific contributions have been recognized through prestigious awards: Pew Biomedical Scholars Award Cottrell Scholar Alfred P. Sloan Research Fellowship American Chemical Society Infectious Disease Young Investigator Award Dreyfus Teacher Scholar Award Dr. Leimkuhler Grimes serves as co-director of an NIH-funded graduate training program at the chemistry-biology interface and mentors undergraduate STEM students through "The Scientistas" initiative. She has advised PhD candidates including Aastha, who recently advanced to candidacy. Her research program receives substantial external funding supporting innovative work in chemical immunology. The Leimkuhler Grimes Group maintains a dedicated intellectual community committed to diversity, collaboration, and professionalism. The lab environment emphasizes clear communication and supports researchers regardless of race, religion, national origin, sexual orientation, gender identity, socioeconomic status, or personal circumstances, fostering an inclusive space for scientific discovery since its founding in 2011.

• Cancer genomics
• Epigenetics
• Tumor metabolism
• +۹ مورد دیگر

Jinpeng Liu, Ph.D., is Assistant Professor of Internal Medicine at the University of Kentucky College of Medicine, with adjunct affiliations to the Center for Computational Sciences, Markey Cancer Center, and the Molecular & Cellular Oncology Research Program. His lab integrates multi-omics and computational modeling to decode oncogenic signaling, epigenetic reprogramming and metabolic rewiring in lung, prostate, neuroblastoma and melanoma. Education: Ph.D., University of Kentucky, 2021 M.S., University of Kentucky, 2014 M.S., Shanxi Medical College, 2009 B.S., Beijing Institute of Technology, 2006 Research Focus: Dr. Liu’s group combines single-cell transcriptomics, DNA-methylation profiling, metabolomics and machine learning to identify therapeutic vulnerabilities in solid tumors. Major themes include: Neurotensin‐AMPK axis in obesity-driven gut and liver cancers Epigenetic regulation of tumor-infiltrating lymphocyte exhaustion in NSCLC Tyrosine-kinase mediated resistance in NRAS-mutant melanoma Stress-signaling and proteostasis nodes in castration-resistant prostate cancer Recent Article Trends (2021-2025): Across 68 publications, Liu’s work exhibits a clear trajectory from descriptive genomics to mechanistic cancer metabolism and immune-microenvironment modulation. Over half of his 2025 papers center on neurotensin as a multi-organ metabolic regulator, while 2023-24 outputs emphasize PLK1-driven immune evasion and combinatorial epigenetic-kinase inhibition strategies. Funding & Awards: He participates in 20 active grants (total 47 since 2013) from NCI, NHLBI, DoD, V-Foundation and AHA, serving as co-investigator on awards totaling >$12 M. Collaborations: Liu co-leads projects with 30+ faculty across Kentucky, Ohio and international sites, providing bioinformatics and metabolomics cores for lung fibrosis, cardio-oncology and pediatric neuroblastoma programs.

Ajay Gulatiمشاهده پروفایل

استاد

• Microbiome
• Inflammatory Bowel Disease
• Intestinal Epithelial Biology
• +۳ مورد دیگر

Ajay Gulati, MD is a Professor at the University of North Carolina at Chapel Hill School of Medicine , holding appointments in both the Department of Pediatrics, Division of Gastroenterology and the Department of Pathology and Laboratory Medicine . His research focuses on gut microbiota-host epithelium interactions in inflammatory bowel diseases (IBD), particularly examining how microbiota regulates Paneth cell and intestinal stem cell function during inflammation. Dr. Gulati has received multiple honors including the NASPGHAN Mid-Level Faculty Investigator Award (2018) and CCFA Young Investigator Award (2010) . Research Themes : Microbiota regulation of intestinal epithelial biology Role of Paneth and stem cells in IBD Microbial modulation of immune responses Age-dependent gut-microbiota interactions Publication Trends show expertise in microbiome analysis (2013–2023), inflammatory bowel diseases , fecal microbiota transplantation , and intestinal epithelial repair . His 2024 studies explore genetic determinants of anti-TNF response and microbial metabolome changes. Scientific Awards : Society of Pediatric Research Membership (2020) NASPGHAN Mid-Level Faculty Investigator Award (2018) KL2, K08, and R03 NIH grants CDHNF/CCFA Young Investigator Award (2010) Education : MD from Baylor College of Medicine (2000) , followed by residency/chief residency (2000–2004) and fellowship (2004–2007) at the same institution. Board-certified in Pediatrics (2003) and Pediatric Gastroenterology (2010).

Rita Tamayoمشاهده پروفایل

دانشیار

• Bacterial Pathogenesis
• Regulatory Mechanisms in Bacteria
• Second Messenger Signaling
• +۵ مورد دیگر

Rita Tamayo, PhD is an Associate Professor in the Department of Microbiology and Immunology at the University of North Carolina at Chapel Hill School of Medicine. She serves as Co-Director of the UNC Initiative for Maximizing Student Development (IMSD) and Chair of the Department's Diversity, Equity & Inclusion Committee. Her laboratory investigates the regulatory mechanisms employed by bacterial pathogens, particularly Clostridioides difficile , to sense, respond, and adapt to host environments. Dr. Tamayo's research focuses on phase variation and phenotypic heterogeneity in C. difficile , which allows the bacterium to switch between different morphotypes (rough and smooth) affecting virulence, biofilm formation, and colonization. Her work also centers on second messenger signaling , especially the role of cyclic diguanylate (c-di-GMP) in regulating flagella, toxins, and other virulence factors. Utilizing bacterial genetics, molecular biology, and animal models, her lab aims to uncover fundamental mechanisms of bacterial adaptation during infection. Analysis of Dr. Tamayo's recent publications reveals a strong emphasis on C. difficile pathogenesis, with particular attention to phase variation mechanisms, c-di-GMP signaling, and host-pathogen interactions. Her work increasingly explores the impact of the gut microbiome and mucus on C. difficile behavior, as well as therapeutic interventions. The research spans molecular, cellular, and in vivo levels, contributing significantly to understanding bacterial survival strategies in dynamic host environments. Scientific awards and recognitions include: Pilot and Feasibility Award 2010 from the Center for Gastrointestinal Biology and Disease (CGIBD) Dr. Tamayo actively mentors graduate students and postdoctoral fellows. Current lab members include PhD students Anchal Mehra, Nicole Gadda, Jilarie Santos Santiago, and Leslie Kent, as well as IRACDA Postdoctoral Fellow Dylan Plaskon. She has secured research funding, including the CGIBD Pilot and Feasibility Award, to support her investigations into bacterial pathogenesis and regulatory mechanisms. The Tamayo Lab, located in Marsico Hall at UNC Chapel Hill, employs a range of techniques including bacterial genetics, molecular biology, biochemistry, and animal models to study C. difficile and other intestinal pathogens. The lab collaborates with researchers across disciplines to address challenges in infectious diseases and microbiome research.

• PET imaging
• cancer research
• tumor microenvironment
• +۵ مورد دیگر

Tove Grönroos is a Docent (Associate Professor) at the University of Turku's Department of Clinical Medicine and Senior Research Fellow leading the Preclinical PET Imaging Unit at the Turku PET Centre. Her dual roles focus on translational PET imaging to address critical gaps in cancer radiotherapy and neurological diagnostics. Her research centers on developing PET tracers for tumor microenvironment analysis, specifically targeting radioresistance biomarkers like hypoxia, energy metabolism dysregulation, and inflammation in solid tumors. She also re-evaluates existing tracers for cancer imaging applications and whole-body metabolic changes affecting treatment outcomes. Recent publications (2021-2024) reveal a strategic focus on oncology (head/neck cancer biomarkers), neurology (neonatal brain injury, neuropathic pain), and diabetes (islet graft imaging). Her work consistently bridges preclinical validation and clinical implementation, with tracers showing promise for treatment planning in radiotherapy. As Head of the Preclinical PET Imaging Unit, she oversees a multidisciplinary team combining small animal PET technology with molecular biology techniques. The unit collaborates extensively with Turku University Hospital and Finnish research institutions to accelerate tracer adoption in clinical settings, particularly for personalized cancer therapy.

Joseph Reynoldsمشاهده پروفایل

دانشیار

• Immunology
• Inflammation
• Autoimmune Diseases
• +۴ مورد دیگر

Joseph Reynolds, PhD, is an Associate Professor and Discipline Chair of Microbiology and Immunology at Rosalind Franklin University of Medicine and Science's Chicago Medical School. He also directs the Center for Cancer Cell Biology, Immunology and Infection and serves as Interim Vice Dean for Research, focusing on inflammatory responses and mucosal immunity. Education: PhD in Microbiology and Immunology, University of Louisville School of Medicine (2007) His laboratory investigates: Th17 cell-mediated inflammation mechanisms in autoimmunity Mucosal immunity roles of IL-17 cytokines in Gulf War Illness, colitis, asthma, and influenza T cell development processes involving pH regulation and receptor glycosylation Dr. Reynolds has maintained consistent publication output since joining Rosalind Franklin in 2013, with significant contributions to understanding cytokine signaling in disease. His work bridges basic immunology and translational applications through the Center for Cancer Cell Biology, Immunology and Infection. As an active mentor and administrator, he oversees graduate student training while leading institutional research initiatives. His laboratory employs advanced immunological techniques to dissect inflammatory pathways with implications for autoimmune and infectious disease therapeutics.